Pivotal Role of Lactate in Aerobic Energy Metabolism

  • X. M. Leverve
  • I. Mustafa
  • F. Peronnet
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1998)

Abstract

A defect in the energy status of the cell is believed to play a central role in the pathophysiology of shock and possibly also of other less severe acute disorders. It has been known for a long time that defects in oxidative energy metabolism could be accompanied by increases in blood lactate concentration, and many efforts have been made during the last decades to use blood lactate levels in acutely ill patients to better understand the pathophysiology and the prognosis of the disease as well as the effects of therapeutic approaches [1–9]. However, the metabolic significance of the lactate anion is very broad and an increase in blood lactate concentration cannot be considered only as a marker of a defect in oxidative energy metabolism.

Keywords

Obesity Carbohydrate Lactate Influenza Adenosine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Groeneveld AB, Rester AD, Nauta JJ, Thijs LG (1987) Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circ Shock 22: 35–53PubMedGoogle Scholar
  2. 2.
    van Lambalgen AA, Runge HC, van den Bos GC, Thijs LG (1988) Regional lactate production in early canine endotoxin shock. Am J Physiol 254: E45–E51PubMedGoogle Scholar
  3. 3.
    Hotchkiss RS, Karl IE (1992) Réévaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 267: 1503–1510PubMedCrossRefGoogle Scholar
  4. 4.
    Barron JT, Parrillo JE (1995) Production of lactic acid and energy metabolism in vascular smooth muscle: effect of dichloroacetate. Am J Physiol 268: H713–H719PubMedGoogle Scholar
  5. 5.
    Vincent J-L, De Backer D (1995) Oxygen uptake/oxygen supply dependency: fact or fiction? Acta Anaesthesiol Scand Suppl 107: 229–237PubMedCrossRefGoogle Scholar
  6. 6.
    Vincent J-L (1995) Lactate levels in critically ill patients. Acta Anaesthesiol Scand Suppl 107: 261–266PubMedCrossRefGoogle Scholar
  7. 7.
    Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent J-L (1996) Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 22: 404–408PubMedCrossRefGoogle Scholar
  8. 8.
    Takala J, Uusaro A, Parviainen I, Ruokonen E (1996) Lactate metabolism and regional lactate exchange after cardiac surgery. New Horizons 4: 483–492PubMedGoogle Scholar
  9. 9.
    Vincent J-L (1996) End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or …? Intensive Care Med 22: 3–5PubMedCrossRefGoogle Scholar
  10. 10.
    Parrillo JE, Parker MM, Natanson C, et al (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113: 227–242PubMedGoogle Scholar
  11. 11.
    Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471–1477PubMedCrossRefGoogle Scholar
  12. 12.
    Thijs LG (1994) Regional or organ blood flow and oxygen consumption: observations in septic shock. Curr Top Intensive Care 1: 101–123Google Scholar
  13. 13.
    Chaudry IH, Zellweger R, Ayala A (1995) The role of bacterial translocation on Kupffer cell immune function following hemorrhage. Prog Clin Biol Res 392: 209–218PubMedGoogle Scholar
  14. 14.
    Ayala A, Chaudry IH (1996) Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6 (suppl 1): S27–S38PubMedCrossRefGoogle Scholar
  15. 15.
    Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D (1994) Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 68: 3667–3673PubMedGoogle Scholar
  16. 16.
    Richter C, Gogvadze V, Laffranchi R, et al (1995) Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271: 67–74PubMedGoogle Scholar
  17. 17.
    Beilharz EJ, Williams CE, Dragunow M, Sirimanne ES, Gluckman PD (1995) Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol Brain Res 29: 1–14PubMedCrossRefGoogle Scholar
  18. 18.
    Krams SM, Egawa H, Quinn MB, et al (1995) Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 59: 621–625PubMedGoogle Scholar
  19. 19.
    Grootendorst AF (1990) Hemodynamic aspects of multiple organ failure. Intensive Care Med 16 (suppl 2): S165–S167PubMedCrossRefGoogle Scholar
  20. 20.
    Lekander BJ, Cerra FB (1990) The syndrome of multiple organ failure. Crit Care Nurs Clin North Am 2: 331–342PubMedGoogle Scholar
  21. 21.
    Deitch EA (1992) Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216: 117–134PubMedCrossRefGoogle Scholar
  22. 22.
    Reilly E,Yucha CB (1994) Multiple organ failure syndrome. Crit Care Nurse 14: 25–26, 28–31Google Scholar
  23. 23.
    Baue AE (1996) MOF/MODS, SIRS: an update. Shock 6 (suppl 1): S1–S5PubMedCrossRefGoogle Scholar
  24. 24.
    Chinnaiyan AM, Dixit VM (1997) Portrait of an executioner: the molecular mechanism of FAS/APO-1-induced apoptosis. Semin Immunol 9: 69–76PubMedCrossRefGoogle Scholar
  25. 25.
    Yuan J (1997) Genetic control of cellular suicide. Reprod Toxicol 11: 377–384PubMedCrossRefGoogle Scholar
  26. 26.
    Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B (1995) The biochemistry of program-med cell death. FASEB J 9: 1277–1287PubMedGoogle Scholar
  27. 27.
    Bernardi P (1996) The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275: 5–9PubMedCrossRefGoogle Scholar
  28. 28.
    Marchetti P, Castedo M, Susin SA, et al (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184: 1155–1160PubMedCrossRefGoogle Scholar
  29. 29.
    Kroemer G, Zamzami N, Susin SA (1997) Mitochondrial control of apoptosis. Immunol Today 18: 44–51PubMedCrossRefGoogle Scholar
  30. 30.
    Graeber TG, Osmanian C, Jacks T, et al (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88–91PubMedCrossRefGoogle Scholar
  31. 31.
    Long X, Boluyt MO, Hipolito ML, et al (1997) p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99: 2635–2643Google Scholar
  32. 32.
    Yun JK, McCormick TS, Judware R, Lapetina EG (1997) Cellular adaptive responses to low oxygen tension: apoptosis and resistance. Neurochem Res 22: 517–521PubMedCrossRefGoogle Scholar
  33. 33.
    Harkness RA (1997) Is post-hypoxic-ischemic cell damage associated with excessive ATP consumption rather than a failure of ATP production? Acta Paediatr 86: 1–5PubMedCrossRefGoogle Scholar
  34. 34.
    Newsholme EA, Leech AR (1990) Control of gluconeogenesis and glycolysis. In: Newsholme EA, Leech AR (eds) Biochemistry for the medical sciences, John Wiley and Sons, Chichester, pp 450–460Google Scholar
  35. 35.
    Leverve X (1995) Amino acid metabolism and gluconeogenesis. In: Cynober L (ed) Amino acid metabolism and therapy in health and nutritional disease. CRC Press, New York, pp 45–56Google Scholar
  36. 36.
    Brooks GA (1986) Lactate production under fully aerobic conditions: the lactate shuttle during rest and exercise. Fed Proc 45: 2924–2929PubMedGoogle Scholar
  37. 37.
    Avogaro A, Toffolo G, Miola M, et al (1996) Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest 98: 108–115PubMedCrossRefGoogle Scholar
  38. 38.
    Douzinas EE, Tsidemiadou PD, Pitaridis MT, et al (1997) The regional production of cytokines and lactate in sepsis- related multiple organ failure. Am J Respir Crit Care Med 155: 53–59PubMedGoogle Scholar
  39. 39.
    Pilkis SJ (1991) Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu Rev Nutr 11: 465–515PubMedCrossRefGoogle Scholar
  40. 40.
    Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H (1986) Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 250: E634–E640PubMedGoogle Scholar
  41. 41.
    Lewandowski ED, White LT (1995) Pyruvate dehydrogenase influences postischemic heart function. Circulation 91: 2071–2079PubMedGoogle Scholar
  42. 42.
    Medina JM, Tabernero A, Tovar JA, Martin-Barrientos J (1996) Metabolic fuel utilization and pyruvate oxidation during the postnatal period. J Inherit Metab Dis 19: 432–442PubMedCrossRefGoogle Scholar
  43. 43.
    Shangraw RE, Jahoor F, Wolfe RR, Lang CH (1996) Pyruvate dehydrogenase inactivity is not responsible for sepsis-induced insulin resistance. Crit Care Med 24: 566–574PubMedCrossRefGoogle Scholar
  44. 44.
    Gore DC, Jahoor F, Hibbert JM, DeMaria EJ (1996) Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 224: 97–102PubMedCrossRefGoogle Scholar
  45. 45.
    Stacpoole PW, Greene YJ (1992) Dichloroacetate. Diabetes Care 15: 785–791PubMedCrossRefGoogle Scholar
  46. 46.
    Carter TC, Coore HG (1995) Effects of pyruvate on pyruvate dehydrogenase kinase of rat heart. Mol Cell Biochem 149: 71–75PubMedCrossRefGoogle Scholar
  47. 47.
    Felig P (1973) The glucose-alanine cycle. Metabolism 22: 179–207PubMedCrossRefGoogle Scholar
  48. 48.
    Pison CM, Chauvin C, Fontaine E, et al (1995) Mechanism of gluconeogenesis inhibition in rat hepatocytes isolated after in vivo hypoxia. Am J Physiol 268: E965–E973PubMedGoogle Scholar
  49. 49.
    Lovejoy J, Newby FD, Gebhart SS, DiGirolamo M (1992) Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism 41: 22–27PubMedCrossRefGoogle Scholar
  50. 50.
    Vettor R, Lombardi AM, Fabris R, et al (1997) Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscles. Metabolism 46: 684–690PubMedCrossRefGoogle Scholar
  51. 51.
    Peronnet F, Burelle Y, Massicotte D, Lavoie C, Hillaire-Marcel C (1997) Respective oxidation of 13C-labeled lactate and glucose ingested simultaneously during exercise. J Appl Physiol 82: 440–446PubMedGoogle Scholar
  52. 52.
    Tascopoulos M, Magistretti PJ (1996) Metabolic coupling between glia and neurons. J Neurosci 16: 877–885Google Scholar
  53. 53.
    Magistretti PJ, Pellerin L (1996) Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex 6: 50–61PubMedCrossRefGoogle Scholar
  54. 54.
    Magistretti PJ, Pellerin L (1996) Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders. Ann NY Acad Sci 111: 380–387CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • X. M. Leverve
  • I. Mustafa
  • F. Peronnet

There are no affiliations available

Personalised recommendations